Dodging the cytokine storm: Delivering ASOs without adverse effects
By
Millie Hoe
26d agoen
Source
bioprocessintl.comDodging the cytokine storm: Delivering ASOs without adverse effectsbioprocessintl.comNonprofit research highlights the potential causes of immune activation side effects in therapeutic oligos.
You might also wanna read
Manufacturing and regulatory hurdles threaten cell and gene therapy progress
The article discusses how manufacturing and regulatory challenges are hindering the progress of cell and gene therapies, particularly in can
Next-generation immune models: bioinks, 3D bioprinting, and future directions
cell.com·1mo ago

Monoallelic PSMB8 variants cause immunodeficiency and autoinflammation through impaired immunoproteasome assembly
This study identifies seven individuals from five unrelated families carrying five distinct monoallelic PSMB8 variants that cause proteasome
cell.com·15d ago

Study reveals molecular mechanism linking statins to muscle side effects via NLRP3 inflammasome and protein-prenylation pathway
This scientific research article investigates the molecular mechanisms behind statin-associated myopathy (muscle side effects). The study fi
Trodelvy's FDA Approval Highlights Cybersecurity Risks in Healthcare Data Infrastructure
The article examines the cybersecurity vulnerabilities exposed by the FDA approval of Trodelvy (sacituzumab govitecan) for metastatic triple
undercodetesting.com·13d agoEfficient mRNA delivery to resting T cells to reverse HIV latency
nature.com·1y ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.